In conclusion, despite the limitations of this study, it can be concluded that localized stem cell administration can accelerate and enhance osseointegration in osteoporosis conditions through various evaluated markers Osx, osteocalcin, collagen type 1, RUNX2, NFATc1, TNFα, and BIV. This evidence concerns the gene RUNX2 and osteoporosis.